Rocket


News + Filings
Transactions





GOLDSTEIN DOV A MD

DateNameSymbolTypeSecuritySharesPriceValueOwnershipReported
01/03/2023Coya Therapeutics, Inc. PurchaseWarrant to Purchase Common Stock5k$7.50$37.5k 01/03/2023
01/03/2023Coya Therapeutics, Inc. PurchaseCommon Stock, par value $0.0001 per share10k$0.00$0 01/03/2023
09/20/2022Gain Therapeutics, Inc. GrantStock Option (right to buy)10.5k$3.50$36.8k 09/20/2022
09/09/2022NeuBase Therapeutics, Inc.OHRPGrantStock option (right to buy)37.6k$0.60$22.6k 09/09/2022
08/19/2021NeuBase Therapeutics, Inc.OHRPGrantStock option (right to buy)38.1k$3.36$128.1k 08/19/2021
06/18/2021NeuBase Therapeutics, Inc.OHRPPurchaseCommon Stock8k$4.75$38k 06/18/2021
09/09/2020NeuBase Therapeutics, Inc.OHRPGrantStock option (right to buy)14.6k$8.80$128.8k 09/09/2020
04/30/2020NeuBase Therapeutics, Inc.OHRPPurchaseCommon Stock10k$6.00$60k 04/30/2020
02/28/2020ADMA BIOLOGICS, INC.ADMAGrantCommon Stock7.5k$0.00$0 02/28/2020
02/28/2020ADMA BIOLOGICS, INC.ADMAGrantEmployee Stock Option (right to buy)15k$2.92$43.7k 02/28/2020
02/28/2020ADMA BIOLOGICS, INC.ADMAGrantCommon Stock7.5k$0.00$0 02/28/2020
07/12/2019NeuBase Therapeutics, Inc.OHRPGrantStock option (right to buy)227.3k$5.39$1.2M 07/12/2019
03/13/2019ADMA BIOLOGICS, INC.ADMAGrantStock Option (right to buy)30k$3.89$116.7k 03/13/2019
06/22/2018ADMA BIOLOGICS, INC.ADMAGrantStock Option (right to buy)17.5k$4.91$85.9k 06/22/2018
06/06/2018Esperion Therapeutics, Inc.ESPRExerciseStock Option (right to buy)8k$17.75$142k 06/06/2018
06/06/2018Esperion Therapeutics, Inc.ESPRExerciseStock Option (right to buy)5k$14.42$72.1k 06/06/2018
06/06/2018Esperion Therapeutics, Inc.ESPROther (disposition)Common Stock8k$0.00$0 06/06/2018
06/06/2018Esperion Therapeutics, Inc.ESPROther (disposition)Common Stock5k$0.00$0 06/06/2018
05/23/2018Esperion Therapeutics, Inc.ESPRGrantStock Option (right to buy)10.1k$38.32$387k 05/23/2018
12/18/2017Esperion Therapeutics, Inc.ESPROther (disposition)Common Stock21.5k$0.00$0 12/18/2017
12/18/2017Esperion Therapeutics, Inc.ESPRExerciseStock Option (right to buy)21.5k$3.70$79.4k 12/18/2017
12/05/2017Esperion Therapeutics, Inc.ESPROther (acquisition)Common Stock38$0.00$0 12/05/2017
06/06/2017ADMA BIOLOGICS, INC.ADMAGrantStock Option (right to buy)53.8k$3.66$197k 06/06/2017
07/24/2012Durata Therapeutics, Inc.DRTXConversionSeries A Preferred Stock16.2M$0.00$0By Aisling Capital III, LP07/24/2012
07/24/2012Durata Therapeutics, Inc.DRTXPurchaseCommon Stock1.1M$9.00$10MBy Aisling Capital III, LP07/24/2012
07/24/2012Durata Therapeutics, Inc.DRTXConversionCommon Stock2M$0.00$0By Aisling Capital III, LP07/24/2012

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy